Curing Kids Cancer Research Grants — Individual & Collaborative
One-year grants to accelerate promising childhood cancer therapies into the clinic, with priority for immunotherapy/targeted therapy, high-grade brain tumors or other hard-to-treat pediatric cancers, and epigenetic/gene therapy; novel tech (omics, AI, gene editing, nanotech) welcomed.
Eligibility Criteria:
-
Children’s Oncology Group (COG) member institutions in North America.
-
PIs at any academic rank (MD and/or PhD).
-
One application per institution total (either Individual or Collaborative) with division-chief endorsement(s).
Funding Details:
-
Individual Grant: USD 150,000 (1 year).
-
Collaborative Grant: up to USD 300,000 (1 year; ≥2 institutions’ heme/onc divisions).
-
Up to 10% indirects; NIH salary cap applies; correlative studies tied to funded clinical trials considered; second-year renewals require full review.
Deadline:
-
Submission due: September 15, 2025 (11:59 p.m.).
-
Awards announced: late 2025; grant term: January 1, 2026 – December 31, 2026.
Where to Go for Further Information:
-
Apply via ProposalCentral (search “Curing Kids Cancer”).
-
RFP/admin questions: [email protected]; [email protected].
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023